ANNUAL REPORT 2017 - ヤクルト本社

← Back to document page

ANNUAL REPORT 2017Year ended March 31, 2017Yakult has conducted its business activities around the world in ways based on Dr. Shirota s philosophy Shirota-ism (preventive medicine, the idea that a healthy intestinal tract leads to a long life, and offering products at a price anyone can afford) as explained on the next help to protect people s health in 38 countries and regions, including Japan, as of March 31, 2017. In addition to fermented milk drinks, Yakult operations in Japan today include a pharmaceuticals business, in which we handle anticancer drugs, as well as a cosmetics business.* Probiotics: Live microorganisms that provide health benefits by improving the balance of intestinal Minoru Shirota, successfully strengthened and cultivated Lactobacillus casei strain Shirota while at Kyoto Imperial University School of Medicine (now Kyoto University).

South Korea 3,604 Japan 9,367 Taiwan 801 Hong Kong 549 The Philippines 2,449 Vietnam 215 India 157 Thailand 2,183 Malaysia 329 Singapore* 242 Indonesia 5,051 Australia* 237 Breakdown is as follows:

  Vietnam